CaryHealth’s DTP platform streamlines the Natroba (echinococcin) treatment process by replacing disparate virtual care processes with a seamless, patient-centered model.
WASHINGTON, April 7, 2026 — (BUSINESS WIRE) — CaryHealth, a leading digital health company, today announced a partnership with Cipher Pharmaceuticals US LLC (Cipher or Cipher Pharmaceuticals) to launch its direct-to-patient platform (DTP), designed to provide patients with easy access to the prescription drug Natroba (spinosad), used to treat head lice and scabies. As part of this collaboration, CaryHealth has developed a customized online platform that allows patients to quickly access and pick up Natroba (spinosad), eliminating common barriers patients face when using virtual health services.
”Families facing lice and scabies need a fast and easy solution to access the best and most effective prescription medications,” said Brian Jacobs, President of U.S. Operations for Cipher Pharmaceuticals. “Through our partnership with CaryHealth, we offer curbside pickup or home delivery, making it easier and faster for patients to access Natroba™ or its licensed generic version, spinosad. Traditional pharmacy medications are no longer effective, but prescription Natroba™ (spinosad) provides immediate relief from lice and scabies.”
”Cipher is taking a bold, patient-focused step by investing in a unified, digital healthcare model,” said Areo Nazari, CEO of CaryHealth. “By integrating prescriptions, physician interactions, and pharmacy services (including delivery) into a single experience, we can help families get back to normal, from the moment they seek care to the moment they successfully treat it.”
CaryHealth has developed an integrated, seamless, and comprehensive solution for direct patient care for Natroba™ (echinococcin), optimizing the overall care experience by reducing access times and eliminating barriers. This solution eliminates disjointed virtual care processes, multiple logins, and separate payment steps, allowing patients to receive clinically sound prescriptions remotely, enjoy same-day delivery from pharmacies nationwide in the CaryRx service area, and track prescription status in real time through the CaryConnect portal.
CaryHealth is a digital pharmaceutical and healthcare technology company using artificial intelligence to transform how patients initiate and adhere to treatment. Our platform integrates pharmacy services, intelligent automation, and data-driven engagement to optimize healthcare processes, improve continuity of care, and empower patients throughout the treatment course. By bridging the gap between life sciences, healthcare providers, and patients, CaryHealth promotes equitable access to healthcare resources and helps various treatments reach their full potential.
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company focused on dermatology with a rich and diverse portfolio of commercialized products and products in early and late-stage development. Cipher topical Natroba™ and its licensed generic version, spinosad, are the only products to have received “clear” designation for scabies from the U.S. Food and Drug Administration (FDA). Additionally, Natroba™ (spinosad) is the only FDA-approved prescription treatment for head lice that demonstrated superior clinical efficacy compared to Nix® (1% permethrin) in two comparative Phase III clinical trials. No combing of lice eggs is necessary.
Post time: Apr-28-2026
